Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.93 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.58 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.58 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.58 |
| ▸ | PLA2G2D | Q9UNK4 | 1/20 | 0.50 |
| ▸ | CDC25B | P30305 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.47 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.46 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.46 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.46 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL70015 | 0.96 | PTPN1 (1.00) | PTPN1NR4A1NR4A2NR4A3PLA2G2D | |
| SCHEMBL29404396 | 0.96 | PTPN1 (1.00) | PTPN1NR4A1NR4A2NR4A3PLA2G2D | |
| SCHEMBL27906674 | 0.95 | PTPN1 (0.96) | PTPN1NR4A1NR4A2NR4A3PLA2G2D | |
| Hydrochloric Acid SCHEMBL11707739 | 0.95 | PTPN1 (0.96) | PTPN1NR4A1NR4A2NR4A3PLA2G2D | |
| Hydrochloric Acid SCHEMBL8522902 | 0.95 | PTPN1 (0.96) | PTPN1NR4A1NR4A2NR4A3PLA2G2D | |
| SCHEMBL8898819 | 0.93 | PTPN1 (0.93) | PTPN1NR4A1NR4A2NR4A3PLA2G2D | |
| SCHEMBL7623416 | 0.90 | PTPN1 (0.87) | PTPN1NR4A1NR4A2NR4A3PLA2G2D | |
| SCHEMBL7746811 | 0.90 | PTPN1 (0.87) | PTPN1NR4A1NR4A2NR4A3PLA2G2D | |
| Ethylene Glycol SCHEMBL27888858 | 0.90 | PTPN1 (0.87) | PTPN1NR4A1NR4A2NR4A3PLA2G2D | |
| Paraben SCHEMBL5690434 | 0.88 | PTPN1 (0.84) | PTPN1NR4A1NR4A2NR4A3PLA2G2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7772181-B2 | Personal care compositions comprising modified variant Bowman Birk Protease Inhibitors | DANISCO US INC. (US) | 2010-08-10 | — | — | US | disclosed |
| US-20100092409-A1 | PERSONAL CARE COMPOSITIONS COMPRISING MODIFIED VARIANT BOWMAN BIRK PROTEASE INHIBITORS | DANISCO US INC. | 2010-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100092409-A1 | PERSONAL CARE COMPOSITIONS COMPRISING MODIFIED VARIANT BOWMAN BIRK PROTEASE INHIBITORS | SERPINB1, CPB1, HABP2 | PTPN1 1374/4885NR4A1 3975/4885NR4A2 4362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.